<DOC>
	<DOCNO>NCT01986361</DOCNO>
	<brief_summary>The study 's purpose demonstrate onset action , i.e. , time meaningful pain relief patient pharyngitis , flurbiprofen 8.75 mg lozenge use Double-Stopwatch Method ( DSW ) .</brief_summary>
	<brief_title>Placebo-Controlled Onset-of-Action Study Flurbiprofen Utilizing Double-Stopwatch Method</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<criteria>Primary diagnosis : pharyngitis confirm TonsilloPharyngitis Assessment ≥ 5 Complaint sore throat onset ≤ 4 day prior randomization Have least one symptom upper respiratory tract infection ( URTI ) URTI Questionnaire ( e.g. , sore throat , runny nose , cough , fever ) Have moderate severe sore throat pain Throat Pain Scale Have baseline Sore Throat Scale ( STS ) ≥ 6 If patient female childbearing potential , use effective contraception since last date menses breastfeed lactating . She also willing take adequate contraceptive precaution 24 hour completion study . If patient female childbearing potential , patient must negative urine pregnancy test ( UPT ) result ( indicate `` pregnant '' ) obtain day schedule randomization , prior designated time randomization The patient willing remain study centre 3 hour receive dose study medication During 3hour evaluation study medication lozenge site , patient willing take `` nothing mouth '' ( e.g. , smoking , food , candy , lozenge , chew gum , liquid ) . Known allergy and/or hypersensitivity aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) , inactive ingredient honey , lemon flavor , menthol , sucrose . History upper gastrointestinal ulcer within past 60 day , current clinically significant upper gastrointestinal complaint , current regular use ( ≥ 3 time previous week ) medication upper gastrointestinal symptom , include antacid , H2 blocker , proton pump inhibitor sucralfate History hepatic disease renal dysfunction Other severe acute chronic medical condition may increase risk associate study participation may interfere interpretation study result , judgment Investigator , would make patient inappropriate entry study . History chronic analgesic use ( ≥ 3 time per week prior 4 week ) Use antibiotic acute disease within previous 24 hour randomization . ( Chronic antibiotic use , acne , acceptable . ) Use quinolone antibiotic ciprofloxacin nalidixic acid within past week concurrently specifically prohibit . Use mifepristone 12 day prior screen visit Use inhale therapy ( e.g. , inhaled steroid βagonists , Ventolin ) acute basis disease exacerbation week prior screen visit Use immediate release analgesic within 4 hour precede administration study medication . Use sustain release analgesic within 12 hour precede administration study medication . Use `` cold medication '' ( i.e . decongestant , antihistamine , expectorant , antitussive ) within 4 hour precede administration dose study medication . Use throat lozenge , throat spray , cough drop , mentholcontaining product within 2 hour precede administration study medication Consumption caffeinecontaining beverage ( e.g. , coffee , tea , hot chocolate , caffeinated soft drink ) within 5 minute precede administration study medication . Any evidence mouthbreathing ( could worsen sore throat pain ) . Coughing cause throat discomfort active physical disease ( bronchopneumonia ) could compromise respiratory function worsen sore throat Unable opinion Investigator comply fully study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Pharyngitis</keyword>
	<keyword>Sore Throat</keyword>
	<keyword>acute upper respiratory tract infection ( URTI )</keyword>
</DOC>